A Study of MK-8033 in Patients With Advanced Solid Tumors (MK-8033-001)

Clinical trial NCT00559182 · COMPLETED

Trial details

NCT number: NCT00559182
Sponsor: Merck Sharp & Dohme LLC
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Advanced Cancer

Start date: 2007-12-05
Primary completion: 2010-06-10
Enrollment: 47

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.